Cargando…
Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study
BACKGROUND: Online patient-provider communication (OPPC) is crucial in enhancing access to health information, self-care, and related health outcomes among cancer survivors. The necessity of OPPC increased during SARS-CoV-2/COVID-19, yet investigations in vulnerable subgroups have been limited. OBJE...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208306/ https://www.ncbi.nlm.nih.gov/pubmed/37074951 http://dx.doi.org/10.2196/44339 |
_version_ | 1785046639712403456 |
---|---|
author | Kim, Jiyeong Linos, Eleni Fishman, Debra A Dove, Melanie S Hoch, Jeffrey S Keegan, Theresa H |
author_facet | Kim, Jiyeong Linos, Eleni Fishman, Debra A Dove, Melanie S Hoch, Jeffrey S Keegan, Theresa H |
author_sort | Kim, Jiyeong |
collection | PubMed |
description | BACKGROUND: Online patient-provider communication (OPPC) is crucial in enhancing access to health information, self-care, and related health outcomes among cancer survivors. The necessity of OPPC increased during SARS-CoV-2/COVID-19, yet investigations in vulnerable subgroups have been limited. OBJECTIVE: This study aims to assess the prevalence of OPPC and sociodemographic and clinical characteristics associated with OPPC among cancer survivors and adults without a history of cancer during COVID-19 versus pre–COVID-19. METHODS: Nationally representative cross-sectional survey data (Health Information National Trends Survey 5, 2017-2020) were used among cancer survivors (N=1900) and adults without a history of cancer (N=13,292). COVID-19 data included data from February to June 2020. We calculated the prevalence of 3 types of OPPC, defined as using the email/internet, tablet/smartphone, or electronic health record (EHR) for patient-provider communication, in the past 12 months. To investigate the associations of sociodemographic and clinical factors with OPPC, multivariable-adjusted weighted logistic regression was performed to obtain odds ratios (ORs) and 95% CIs. RESULTS: The average prevalence of OPPC increased from pre-COVID to COVID among cancer survivors (39.7% vs 49.7%, email/internet; 32.2% vs 37.9%, tablet/smartphone; 19.0% vs 30.0%, EHR). Cancer survivors (OR 1.32, 95% CI 1.06-1.63) were slightly more likely to use email/internet communications than adults without a history of cancer prior to COVID-19. Among cancer survivors, the email/internet (OR 1.61, 95% CI 1.08-2.40) and EHRs (OR 1.92, 95% CI 1.22-3.02) were more likely to be used during COVID-19 than pre–COVID-19. During COVID-19, subgroups of cancer survivors, including Hispanics (OR 0.26, 95% CI 0.09-0.71 vs non-Hispanic Whites) or those with the lowest income (US $50,000-<US $75,000: OR 6.14, 95% CI 1.99-18.92; ≥US $75,000: OR 0.42, 95% CI 1.56-11.28 vs <US $20,000), with no usual source of care (OR 6.17, 95% CI 2.12-17.99), or reporting depression (OR 0.33, 95% CI 0.14-0.78) were less likely to use email/internet, and those who were the oldest (age 35-49 years: OR 9.33, 95% CI 2.18-40.01; age 50-64 years: OR 3.58, 95% CI 1.20-10.70; age 65-74 years: OR 3.09, 95% CI 1.09-8.76 vs age≥75 years), were unmarried (OR 2.26, 95% CI 1.06-4.86), or had public/no health insurance (Medicare, Medicaid, or other: ORs 0.19-0.21 vs private) were less likely to use a tablet/smartphone to communicate with providers. Cancer survivors with a usual source of care (OR 6.23, 95% CI 1.66-23.39) or health care office visits in a year (ORs 7.55-8.25) were significantly more likely to use EHRs to communicate. Although it was not observed in cancer survivors, a lower education level was associated with lower OPPC among adults without a history of cancer during COVID-19. CONCLUSIONS: Our findings identified vulnerable subgroups of cancer survivors who were left behind in OPPC, which is increasingly becoming part of health care. These vulnerable subgroups of cancer survivors with lower OPPC should be helped through multidimensional interventions to prevent further inequities. |
format | Online Article Text |
id | pubmed-10208306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-102083062023-05-25 Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study Kim, Jiyeong Linos, Eleni Fishman, Debra A Dove, Melanie S Hoch, Jeffrey S Keegan, Theresa H JMIR Cancer Original Paper BACKGROUND: Online patient-provider communication (OPPC) is crucial in enhancing access to health information, self-care, and related health outcomes among cancer survivors. The necessity of OPPC increased during SARS-CoV-2/COVID-19, yet investigations in vulnerable subgroups have been limited. OBJECTIVE: This study aims to assess the prevalence of OPPC and sociodemographic and clinical characteristics associated with OPPC among cancer survivors and adults without a history of cancer during COVID-19 versus pre–COVID-19. METHODS: Nationally representative cross-sectional survey data (Health Information National Trends Survey 5, 2017-2020) were used among cancer survivors (N=1900) and adults without a history of cancer (N=13,292). COVID-19 data included data from February to June 2020. We calculated the prevalence of 3 types of OPPC, defined as using the email/internet, tablet/smartphone, or electronic health record (EHR) for patient-provider communication, in the past 12 months. To investigate the associations of sociodemographic and clinical factors with OPPC, multivariable-adjusted weighted logistic regression was performed to obtain odds ratios (ORs) and 95% CIs. RESULTS: The average prevalence of OPPC increased from pre-COVID to COVID among cancer survivors (39.7% vs 49.7%, email/internet; 32.2% vs 37.9%, tablet/smartphone; 19.0% vs 30.0%, EHR). Cancer survivors (OR 1.32, 95% CI 1.06-1.63) were slightly more likely to use email/internet communications than adults without a history of cancer prior to COVID-19. Among cancer survivors, the email/internet (OR 1.61, 95% CI 1.08-2.40) and EHRs (OR 1.92, 95% CI 1.22-3.02) were more likely to be used during COVID-19 than pre–COVID-19. During COVID-19, subgroups of cancer survivors, including Hispanics (OR 0.26, 95% CI 0.09-0.71 vs non-Hispanic Whites) or those with the lowest income (US $50,000-<US $75,000: OR 6.14, 95% CI 1.99-18.92; ≥US $75,000: OR 0.42, 95% CI 1.56-11.28 vs <US $20,000), with no usual source of care (OR 6.17, 95% CI 2.12-17.99), or reporting depression (OR 0.33, 95% CI 0.14-0.78) were less likely to use email/internet, and those who were the oldest (age 35-49 years: OR 9.33, 95% CI 2.18-40.01; age 50-64 years: OR 3.58, 95% CI 1.20-10.70; age 65-74 years: OR 3.09, 95% CI 1.09-8.76 vs age≥75 years), were unmarried (OR 2.26, 95% CI 1.06-4.86), or had public/no health insurance (Medicare, Medicaid, or other: ORs 0.19-0.21 vs private) were less likely to use a tablet/smartphone to communicate with providers. Cancer survivors with a usual source of care (OR 6.23, 95% CI 1.66-23.39) or health care office visits in a year (ORs 7.55-8.25) were significantly more likely to use EHRs to communicate. Although it was not observed in cancer survivors, a lower education level was associated with lower OPPC among adults without a history of cancer during COVID-19. CONCLUSIONS: Our findings identified vulnerable subgroups of cancer survivors who were left behind in OPPC, which is increasingly becoming part of health care. These vulnerable subgroups of cancer survivors with lower OPPC should be helped through multidimensional interventions to prevent further inequities. JMIR Publications 2023-05-22 /pmc/articles/PMC10208306/ /pubmed/37074951 http://dx.doi.org/10.2196/44339 Text en ©Jiyeong Kim, Eleni Linos, Debra A Fishman, Melanie S Dove, Jeffrey S Hoch, Theresa H Keegan. Originally published in JMIR Cancer (https://cancer.jmir.org), 22.05.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on https://cancer.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Kim, Jiyeong Linos, Eleni Fishman, Debra A Dove, Melanie S Hoch, Jeffrey S Keegan, Theresa H Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study |
title | Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study |
title_full | Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study |
title_fullStr | Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study |
title_full_unstemmed | Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study |
title_short | Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study |
title_sort | factors associated with online patient-provider communications among cancer survivors in the united states during covid-19: cross-sectional study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208306/ https://www.ncbi.nlm.nih.gov/pubmed/37074951 http://dx.doi.org/10.2196/44339 |
work_keys_str_mv | AT kimjiyeong factorsassociatedwithonlinepatientprovidercommunicationsamongcancersurvivorsintheunitedstatesduringcovid19crosssectionalstudy AT linoseleni factorsassociatedwithonlinepatientprovidercommunicationsamongcancersurvivorsintheunitedstatesduringcovid19crosssectionalstudy AT fishmandebraa factorsassociatedwithonlinepatientprovidercommunicationsamongcancersurvivorsintheunitedstatesduringcovid19crosssectionalstudy AT dovemelanies factorsassociatedwithonlinepatientprovidercommunicationsamongcancersurvivorsintheunitedstatesduringcovid19crosssectionalstudy AT hochjeffreys factorsassociatedwithonlinepatientprovidercommunicationsamongcancersurvivorsintheunitedstatesduringcovid19crosssectionalstudy AT keegantheresah factorsassociatedwithonlinepatientprovidercommunicationsamongcancersurvivorsintheunitedstatesduringcovid19crosssectionalstudy |